PHOTO
Dubai, UAE - Intertek, a Total Quality Assurance provider to industries worldwide, announced it has signed a Memorandum of Understanding (MoU) with PRECISE, a leading distributor of corporate products in the Gulf, to test its antimicrobial protective films for high-contact surfaces. Intertek will exclusively provide independent COVID-19 SWAB testing for MEDG, the nano-copper antimicrobial film solution from PRECISE.
Intertek’s COVID-19 testing service is part of Intertek Protek, the world’s first health, safety and wellbeing assurance programme for people, workplaces and public spaces. The Protek programme provides support across all sectors, from manufacturing to retail sites to public places, schools, hospitals, transport, banks, amongst others. As part of the MoU, Intertek will offer COVID-19 surface testing services to PRECISE customers to independently verify the product’s performance. PRECISE has launched its bacteria and virus resisting transparent films in the UAE and Saudi markets. A pre-launch campaign saw the company apply its antimicrobial protective films on high-contact touch surfaces of a public bus. After a month-long trial that included only standard cleaning and maintenance, Intertek conducted surface testing of the film-protected surfaces from high-traffic areas on the public transportation vehicle and verified that the active antimicrobial nano copper films were COVID-19 free after 28 days at the end of the trial period.
Lother Hohman, President of PRECISE, explains: “We were delighted to work with Intertek, a global industry leader in quality assurance. Active Antimicrobial Nano Copper technology uses active copper nano particles that deactivates pathogens with amazing results. Copper ions quickly inactivate viruses and bacteria by immobilising all life support systems in their cells. Science tells us that applying the protective nano-copper anti-microbial film helps to reduce the risks of cross-contamination. This novel composite film also significantly reduces the direct cost of continuous disinfection protocols through traditional methods.”
Samir Ahmed, Regional Director for Products and Marketing for the Middle East, North Africa and Pakistan at Intertek concludes: “Intertek has been at the forefront, driving a health, safety, and well-being assurance agenda globally when it launched its Protek solution, the first comprehensive offering in the world for quality assurance services that provide the confidence people need to operate in the post-COVID-19 ‘new normal’. Intertek uses cutting-edge technology and solutions to test and verify germicidal devices and products to support manufacturers who wish to assess equipment performance and compliance in the impacted environment. Our collaboration with PRECISE is aligned with our global and regional strategies and will provide our clients the peace of mind they need to live and work safely in a protected environment.”
© Press Release 2021
Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.
The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.
To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.
